Antimicrobial susceptibility and molecular typing of MRSA in cystic fibrosis

Pediatric Pulmonology

Volumn 49, Issue 3, 2014, Pages 230-237

  Champion, E A ^a   Miller, M B ^a   Popowitch, E B ^a   Hobbs, M M ^a   Saiman, L ^b,c   Muhlebach, M S ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b NewYork Presbyterian Hospital   (United States)

^c NEW YORK PRESBYTERIAN HOSPITAL   (United States)

Author keywords

community MRSA; hospital MRSA; multi center study; Panton Valentine leukocidin; spa typing; staphylococcal cassette chromosome mec

Indexed keywords

COMMUNITY MRSA; HOSPITAL MRSA; MULTI-CENTER STUDY; PANTON-VALENTINE LEUKOCIDIN; SPA-TYPING; STAPHYLOCOCCAL CASSETTE CHROMOSOME MEC;

ACETAMIDES; ADOLESCENT; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BACTERIAL TOXINS; BRONCHOSCOPY; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; CYSTIC FIBROSIS; DNA, BACTERIAL; EXOTOXINS; FEMALE; FOSFOMYCIN; FUSIDIC ACID; HUMANS; LEUKOCIDINS; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; MINOCYCLINE; MOLECULAR TYPING; MUPIROCIN; OXAZOLIDINONES; PHARYNX; PNEUMONIA, STAPHYLOCOCCAL; SEQUENCE ANALYSIS, DNA; SPUTUM; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCAL PROTEIN A; TETRACYCLINE; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION; UNITED STATES;

EID: 84894276157     PISSN: 87556863     EISSN: 10990496     Source Type: Journal    
DOI: 10.1002/ppul.22815     Document Type: Article

References (32)

1. Boucher RC,. Evidence for airway surface dehydration as the initiating event in CF airway disease. J Intern Med 2007; 261: 5-16.
2. Saiman L,. Microbiology of early CF lung disease. Paediatr Respir Rev 2004; 5: S367-S369.
3. Crum NF, Lee RU, Thornton SA, Stine OC, Wallace MR, Barrozo C, Keefer-Norris A, Judd S, Russell KL,. Fifteen-year study of the changing epidemiology of methicillin-resistant Staphylococcus aureus. Am J Med 2006; 119: 943-951.
4. CF Foundation. Cystic Fibrosis Patient Registry. 2010, 2012.
5. Ren CL, Morgan WJ, Konstan MW, Schechter MS, Wagener JS, Fisher KA, Regelmann WE,. Presence of methicillin resistant Staphylococcus aureus in respiratory cultures from cystic fibrosis patients is associated with lower lung function. Pediatr Pulmonol 2007; 42: 513-518.
6. Elizur A, Orscheln RC, Ferkol TW, Atkinson JJ, Dunne WM, Jr., Buller RS, Armstrong JR, Mardis ER, Storch GA, Cannon CL,. Panton-Valentine Leukocidin-positive methicillin-resistant Staphylococcus aureus lung infection in patients with cystic fibrosis. Chest 2007; 131: 1718-1725.
7. Taccetti G, Neri AS, Festini F, Galici V, Cocchi P, Campana S,. Methicillin resistant Staphylococcus aureus in cystic fibrosis. Pediatr Pulmonol 2008; 43: 309.
8. Dasenbrook EC, Checkley W, Merlo CA, Konstan MW, Lechtzin N, Boyle MP,. Association between respiratory tract methicillin-resistant Staphylococcus aureus and survival in cystic fibrosis. JAMA 2010; 303: 2386-2392.
9. Dasenbrook EC, Merlo CA, Diener-West M, Lechtzin N, Boyle MP,. Persistent methicillin-resistant Staphylococcus aureus and rate of FEV1 decline in cystic fibrosis. Am J Respir Crit Care Med 2008; 178: 814-821.
10. Tenover FC, McAllister S, Fosheim G, McDougal LK, Carey RB, Limbago B, Lonsway D, Patel JB, Kuehnert MJ, Gorwitz R,. Characterization of Staphylococcus aureus isolates from nasal cultures collected from individuals in the United States in 2001 to 2004. J Clin Microbiol 2008; 46: 2837-2841.
11. Okuma K, Iwakawa K, Turnidge JD, Grubb WB, Bell JM, O'Brien FG, Coombs GW, Pearman JW, Tenover FC, Kapi M, Tiensasitorn C, Ito T, Hiramatsu K,. Dissemination of new methicillin-resistant Staphylococcus aureus: a meta-analysis of prevalence and risk factors. J Clin Microbiol 2002; 40: 4289-4294.
12. Salgado CD, Farr BM, Calfee DP,. Community-acquired methicillin-resistant Staphylococcus aureus: a meta-analysis of prevalence and risk factors. Clin Infect Dis 2003; 36: 131-139.
13. David MZ, Glikman D, Crawford SE, Peng J, King KJ, Hostetler MA, Boyle-Vavra S, Daum RS,. What is community-associated methicillin-resistant Staphylococcus aureus ? J Infect Dis 2008; 197: 1235-1243.
14. Shopsin B, Gomez M, Montgomery SO, Smith DH, Waddington M, Dodge DE, Bost DA, Riehman M, Naidich S, Kreiswirth BN,. Evaluation of protein A gene polymorphic region DNA sequencing for typing of Staphylococcus aureus strains. J Clin Microbiol 1999; 37: 3556-3563.
15. Church DL, Chow BL, Lloyd T, Gregson DB,. Comparison of automated repetitive-sequence-based polymerase chain reaction and spa typing versus pulsed-field gel electrophoresis for molecular typing of methicillin-resistant Staphylococcus aureus. Diagn Microbiol Infect Dis 2011; 69: 30-37.
16. Cookson BD, Robinson DA, Monk AB, Murchan S, Deplano A, de Ryck R, Struelens MJ, Scheel C, Fussing V, Salmenlinna S, Vuopio-Varkila J, Cuny C, Witte W, Tassios PT, Legakis NJ, van Leeuwen W, van Belkum A, Vindel A, Garaizar J, Haeggman S, Olsson-Liljequist B, Ransjo U, Muller-Premru M, Hryniewicz W, Rossney A, O'Connell B, Short BD, Thomas J, O'Hanlon S, Enright MC,. Evaluation of molecular typing methods in characterizing a European collection of epidemic methicillin-resistant Staphylococcus aureus strains: the HARMONY collection. J Clin Microbiol 2007; 45: 1830-1837.
17. Saiman L, Siegel J,. Infection control recommendations for patients with cystic fibrosis: microbiology, important pathogens, and infection control practices to prevent patient-to-patient transmission. Infect Control Hosp Epidemiol 2003; 24: S6-S52.
18. Boye K, Bartels MD, Andersen IS, Moller JA, Westh H,. A new multiplex PCR for easy screening of methicillin-resistant Staphylococcus aureus SCCmec types I-V. Clin Microbiol Infect 2007; 13: 725-727.
19. Nakagawa S, Taneike I, Mimura D, Iwakura N, Nakayama T, Emura T, Kitatsuji M, Fujimoto A, Yamamoto T,. Gene sequences and specific detection for Panton-Valentine leukocidin. Biochem Biophys Res Commun 2005; 328: 995-1002.
20. Goodrich JS, Sutton-Shields TN, Kerr A, Wedd JP, Miller MB, Gilligan PH,. Prevalence of community-associated methicillin-resistant Staphylococcus aureus in patients with cystic fibrosis. J Clin Microbiol 2009; 47: 1231-1233.
21. Deurenberg RH, Stobberingh EE,. The molecular evolution of hospital- and community-associated methicillin-resistant Staphylococcus aureus. Curr Mol Med 2009; 9: 100-115.
22. Harmsen D, Claus H, Witte W, Rothganger J, Claus H, Turnwald D, Vogel U,. Typing of methicillin-resistant Staphylococcus aureus in a university hospital setting by using novel software for spa repeat determination and database management. J Clin Microbiol 2003; 41: 5442-5448.
23. Cocchi P, Cariani L, Favari F, Lambiase A, Fiscarelli E, Gioffre FV, d'Aprile A, Manso E, Taccetti G, Braggion C, Doring G, de Martino M, Campana S,. Molecular epidemiology of meticillin-resistant Staphylococcus aureus in Italian cystic fibrosis patients: a national overview. J Cyst Fibros 2011; 10: 407-411.
24. Muhlebach MS, Miller M, LaVange LM, Mayhew G, Goodrich JS, Miller MB,. Treatment intensity and characteristics of MRSA infection in CF. J Cyst Fibros 2011; 10: 201-206.
25. Glikman D, Siegel JD, David MZ, Okoro NM, Boyle-Vavra S, Dowell ML, Daum RS,. Complex molecular epidemiology of methicillin-resistant Staphylococcus aureus isolates from children with cystic fibrosis in the era of epidemic community-associated methicillin-resistant S aureus. Chest 2008; 133: 1381-1387.
26. Gordon RJ, Lowy FD,. Pathogenesis of methicillin-resistant Staphylococcus aureus infection. Clin Infect Dis 2008; 46: S350-S359.
27. Gonzalez BE, Martinez-Aguilar G, Hulten KG, Hammerman WA, Coss-Bu J, Avalos-Mishaan A, Mason EO, Jr., Kaplan SL,. Severe Staphylococcal sepsis in adolescents in the era of community-acquired methicillin-resistant Staphylococcus aureus. Pediatrics 2005; 115: 642-648.
28. CDC. Use of an inferred PFGE algorithm, emerging infections program/active bacterial core (ABCs) surveillance invasive MRSA project. Volume 2012. Atlanta, GA: Centers for Disease Control and Prevention; 2009.
29. Said-Salim B, Mathema B, Braughton K, Davis S, Sinsimer D, Eisner W, Likhoshvay Y, Deleo FR, Kreiswirth BN,. Differential distribution and expression of Panton-Valentine leucocidin among community-acquired methicillin-resistant Staphylococcus aureus strains. J Clin Microbiol 2005; 43: 3373-3379.
30. Lafaurie M, Porcher R, Donay JL, Touratier S, Molina JM,. Reduction of fluoroquinolone use is associated with a decrease in methicillin-resistant Staphylococcus aureus and fluoroquinolone-resistant Pseudomonas aeruginosa isolation rates: a 10 year study. J Antimicrob Chemother 2012; 67: 1010-1015.
31. Kahl B, Herrmann M, Everding AS, Koch HG, Becker K, Harms E, Proctor RA, Peters G,. Persistent infection with small colony variant strains of Staphylococcus aureus in patients with cystic fibrosis. J Infect Dis 1998; 177: 1023-1029.
32. Besier S, Zander J, Kahl BC, Kraiczy P, Brade V, Wichelhaus TA,. The thymidine-dependent small-colony-variant phenotype is associated with hypermutability and antibiotic resistance in clinical Staphylococcus aureus isolates. Antimicrob Agents Chemother 2008; 52: 2183-2189.